NAHSV Healthlinko Private Limited has completed its first year of operations, reporting strong growth, profitability, expanding patient reach, and early international expansion through its flagship healthcare platform, MediFyr.
Since its incorporation in April 2025, the company has focused on building technology-led healthcare access solutions designed to simplify how patients discover, navigate and connect with medical services. Over the past year, that strategy has translated into measurable operating momentum, with MediFyr emerging as the company’s primary growth engine.
The company stated that more than 2,000 patients are currently supported every month through MediFyr for medical needs, consultations, treatment discovery and related healthcare access support. This growing patient base has contributed to strong commercial traction, with the company recording ₹65 lakh in revenue in the last quarter of the previous financial year.
According to the company, these milestones were achieved while operating as a bootstrapped and profitable business, without raising external investment. Management said the company’s growth has been driven through disciplined execution, sustainable unit economics and a focus on building long-term value.
While many early-stage companies prioritize rapid scale through capital-intensive models, NAHSV Healthlinko said its approach has centered on building a stronger operational foundation first, allowing growth to be supported by business fundamentals.
Alongside MediFyr, the company has also continued developing a broader portfolio that includes Zerunio, WhatPregnant, HealthSetu and Unikorn, supporting its strategy of creating a diversified digital health and wellness ecosystem.
The company said international expansion will be a major focus in its second year, with MediFyr already establishing hospital partnerships across Turkey, Egypt, Israel, Thailand, UAE and China. These partnerships are expected to strengthen the company’s cross-border healthcare access model and support its expansion into international patient facilitation.
Management said the goal is to use these early partnerships as a foundation for deeper international presence while continuing to expand patient reach in domestic markets.
“Completing one year is both a milestone and a validation of what can be built with focus, discipline and long-term thinking,” the company said. “The progress made through MediFyr, both in patient growth and international partnerships, creates a strong base for our next stage of scale.”
NAHSV Healthlinko said year two priorities will include expanding the MediFyr network, strengthening technology infrastructure, growing strategic partnerships, and increasing the reach of its broader brand ecosystem.
The company added that its focus remains on creating practical, scalable solutions that improve healthcare access while building a sustainable business positioned for long-term growth.
With profitable operations, growing patient demand and international partnerships already in place, NAHSV Healthlinko said it sees significant opportunity ahead as it enters its second year.
This press release is provided by a third party. The website does not verify its accuracy and is not responsible for its content or any resulting claims.